Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Langhans, Claudia ^a   Weber Carstens, Steffen ^a   Schmidt, Franziska ^a   Hamati, Jida ^a   Kny, Melanie ^a   Zhu, Xiaoxi ^a   Wollersheim, Tobias ^a   Koch, Susanne ^a   Krebs, Martin ^a   Schulz, Herbert ^b   Lodka, Doerte ^a   Saar, Kathrin ^b   Labeit, Siegfried ^c   Spies, Claudia ^a   Hubner, Norbert ^b   Spranger, Joachim ^a   Spuler, Simone ^a   Boschmann, Michael ^a   Dittmar, Gunnar ^b   Butler Browne, Gillian ^d   Mouly, Vincent ^d   Fielitz, Jens ^a   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; SERUM AMYLOID A; SERUM AMYLOID A 1; SERUM AMYLOID A 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; LIPOPOLYSACCHARIDE; SAA1 PROTEIN, HUMAN; SAA4 PROTEIN, HUMAN;

ACUTE PHASE RESPONSE; ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTENSIVE CARE UNIT; MALE; MOUSE; MUSCLE BIOPSY; MUSCLE FIBER MEMBRANE; MYOBLAST; MYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; ANIMAL; BLOOD; CASE CONTROL STUDY; COMPLICATION; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MEMBRANE; METABOLISM; MIDDLE AGED; MUSCLE DISEASE; PATHOLOGY;

ACUTE-PHASE REACTION; ADULT; ANIMALS; CASE-CONTROL STUDIES; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MEMBRANES; MICE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEPSIS; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925287368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092048     Document Type: Article

References (39)

1. Bierbrauer J, Koch S, Olbricht C, Hamati J, Lodka D, et al. (2012) Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 40: 647-650.
2. Lefaucheur JP, Nordine T, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77: 500-506.
3. Bolton CF, Young GB, Zochodne DW (1993) The neurological complications of sepsis. Ann Neurol 33: 94-100. (Pubitemid 23009915)
4. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, et al. (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. Jama 288: 2859-2867. (Pubitemid 35425072)
5. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, et al. (2011) Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364: 1293-1304.
6. Helliwell TR, Wilkinson A, Griffiths RD, McClelland P, Palmer TE, et al. (1998) Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 24: 507-517. (Pubitemid 29002282)
7. Callahan LA, Supinski GS (2009) Sepsis-induced myopathy. Crit Care Med 37: S354-367.
8. Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, et al. (2009) Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 37: 2632-2637.
9. Ali NA, O'Brien JM Jr, Hoffmann SP, Phillips G, Garland A, et al. (2008) Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 178: 261-268.
10. Kress JP, Herridge MS (2012) Medical and economic implications of physical disability of survivorship. Semin Respir Crit Care Med 33: 339-347.
11. Weber-Carstens S, Schneider J, Wollersheim T, Assmann A, Bierbrauer J, et al. (2012) Critical Illness Myopathy and GLUT4 - Significance of Insulin and Muscle Contraction. Am J Respir Crit Care Med.
12. Friedrich O (2006) Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 9: 403-409.
13. Winkelman C (2010) The role of inflammation in ICU-acquired weakness. Crit Care 14: 186.
14. Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, et al. (2010) Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 14: R119.
15. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, et al. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215: 356-362.
16. Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-357. (Pubitemid 17010024)
17. Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, et al. (1996) Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 97: 244-249. (Pubitemid 26022595)
18. Zimmers TA, McKillop IH, Pierce RH, Yoo JY, Koniaris LG (2003) Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology 38: 326-334. (Pubitemid 36919853)
19. Adams V, Mangner N, Gasch A, Krohne C, Gielen S, et al. (2008) Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice. JMol Biol 384: 48-59.
20. Anker SD, Clark AL, Kemp M, Salsbury C, Teixeira MM, et al. (1997) Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 30: 997-1001. (Pubitemid 27435893)
21. Phillips T, Leeuwenburgh C (2005) Muscle fiber specific apoptosis and TNFalpha signaling in sarcopenia are attenuated by life-long calorie restriction. Faseb J 19: 668-670.
22. Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, et al. (1992) Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 127: 170-174.
23. Goodman MN (1991) Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 260: E727-730.
24. Uhlar CM, Whitehead AS (1999) Serum amyloid A, the major vertebrate acutephase reactant. Eur J Biochem 265: 501-523. (Pubitemid 29488982)
25. Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, et al. (2011) STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 6: e22538.
26. Zhang L, Du J, Hu Z, Han G, Delafontaine P, et al. (2009) IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 20: 604-612.
27. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 41: 580-637.
28. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ (1996) Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 46: 731-736. (Pubitemid 26099640)
29. Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, et al. (2011) Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 82: 287-293.
30. Fielitz J, Kim MS, Shelton JM, Latif S, Spencer JA, et al. (2007) Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest 117: 2486-2495. (Pubitemid 47494350)
31. Zhang N, Ahsan MH, Purchio AF, West DB (2005) Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J Immunol 174: 8125-8134. (Pubitemid 40806324)
32. Doyle A, Zhang G, Abdel Fattah EA, Eissa NT, Li YP (2011) Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. Faseb J 25: 99-110.
33. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4: 31-36.
34. Lowell CA, Potter DA, Stearman RS, Morrow JF (1986) Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem 261: 8442-8452. (Pubitemid 17202725)
35. de Beer MC, de Beer FC, Gerardot CJ, Cecil DR, Webb NR, et al. (1996) Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics 34: 139-142. (Pubitemid 26159886)
36. Steel DM, Sellar GC, Uhlar CM, Simon S, DeBeer FC, et al. (1993) A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). Genomics 16: 447-454. (Pubitemid 23170901)
37. Foyn Bruun C, Sletten K, Marhaug G (1998) Mouse serum amyloid A (SAA) proteins isolated by two-dimensional electrophoresis: characterization of isotypes and the effect of separate and combined administrations of cytokines, dexamethasone and lipopolysaccharide (LPS) on serum levels and isotype distribution. Clin Exp Immunol 111: 231-236. (Pubitemid 28062803)
38. Furuya DT, Neri EA, Poletto AC, Anhe GF, Freitas HS, et al. (2013) Identification of nuclear factor-kappaB sites in the Slc2a4 gene promoter. Mol Cell Endocrinol 370: 87-95.
39. Filippin-Monteiro FB, de Oliveira EM, Sandri S, Knebel FH, Albuquerque RC, et al. (2012) Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance. Int J Obes (Lond) 36: 1032-1039.